SLC5A2 and hydrops fetalis: Yet, new management of HF with sodium-glucose cotransporter 2 (SGLT2) inhibitors was found to be effective in improving clinical outcomes regardless of the circulating levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) [10,11].